Examkin

Question

Difficulty: EasyDepressive Disorders

A 26-year-old man comes to the clinic for a follow-up visit. Three weeks ago, he was diagnosed with major depressive disorder after presenting with a 6-week history of depressed mood, anhedonia, significant weight loss, and severe fatigue. At his initial evaluation, a comprehensive psychiatric history confirmed the absence of any past episodes of abnormally elevated mood, impulsivity, or decreased need for sleep. He was started on sertraline 50 mg daily. Today, the patient reports that his sleep has improved slightly, but he still feels sad most days and lacks the energy to resume his usual hobbies. He denies suicidal ideation, auditory hallucinations, or racing thoughts. His vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in management?

  1. Continue sertraline at the current dosage and reassess in 2 to 3 weeksAnswer
  2. B
    Add phenelzine to the current regimen to augment the antidepressant response
  3. C
    Discontinue sertraline and initiate monotherapy with a mood stabilizer
  4. D
    Reclassify the diagnosis as schizophreniform disorder based on symptom duration
  5. E
    Contact the patient's next-of-kin to establish a surrogate decision-maker

Answer

Continue sertraline at the current dosage and reassess in 2 to 3 weeks
The correct course of action is to continue the current medication and wait. Selective serotonin reuptake inhibitors (SSRIs) generally require 4 to 6 weeks to achieve their full therapeutic effect. Because this patient is only at week 3 of treatment, has already demonstrated slight clinical improvement (improved sleep), and is tolerating the medication well without adverse effects or worsening suicidality, it is premature to increase the dose, augment the medication, or switch to a different class.

Step-by-Step Solution

1
Evaluate the patient's current diagnosis and treatment duration.
The patient has unipolar major depressive disorder and has been taking an SSRI (sertraline) for exactly 3 weeks.
Establishing the timeline of treatment is critical for evaluating the efficacy of pharmacotherapy in psychiatry.
2
Assess the clinical response and tolerability.
The patient shows slight improvement (better sleep) and no reported adverse effects or worsening of symptoms.
This confirms the medication is being tolerated and has begun to show early signs of clinical benefit.
3
Apply pharmacological knowledge of SSRI onset of action.
SSRIs require 4 to 6 weeks for a full therapeutic trial. Therefore, changing the regimen at 3 weeks is premature.
Brain neuroplasticity and receptor downregulation take several weeks to translate increased synaptic serotonin into maximal mood improvement.

Key Concept

Selective serotonin reuptake inhibitors (SSRIs) typically require an adequate trial of 4 to 6 weeks at a therapeutic dose to achieve maximal clinical efficacy in treating major depressive disorder.
Estimated Time:1m 0s
Rate this question

Topics

Depressive Disorders

More questions from this topic